Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of Vicagrel in Healthy Subjects
NCT04919551Phase 1Completed
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Aug 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vicagrel in acute coronary syndrome (ACS) (3 arms), sponsored by Jiangsu Vcare PharmaTech Co., Ltd. Primary endpoints: Area Under the Curve at 48 hours and Maximum Plasma Concentration at 48 hours. Started Aug 2021; status: completed.
02
Drugs
vicagrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04919551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04919551.